KUALA LUMPUR – Almost one million doses of the Sinovac Covid-19 vaccine from China are expected to be administered by the end of the month, says Pharmaniaga Bhd managing director Datuk Zulkarnain Md Eusope.
He said this will be possible after obtaining the batch manufacturing process validation and vaccine stability study data by mid-April, to complete the registration application before it is approved by the National Pharmaceutical Regulatory Division (NPRA).
The first dose of the vaccine was administered on March 18.
“To date, we have provided almost 200,000 vials to the Health Ministry.
“We are also in the process of obtaining NPRA’s approval for the fill and finish product, which is currently in our factory, numbering about 300,000 doses.
“We have also received about 400l (of the vaccine liquid) and will carry out the fill and finish process at our factory.”
Zulkarnain said the target will help meet the government’s expectation that Pharmaniaga will be able to produce two million doses of the Sinovac vaccine every month to ensure a stable supply in Malaysia. – Bernama, April 1, 2021
